Cargando…

Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis

We aimed to examine the effect of Wisteria floribunda agglutinin-positive Mac-2-binding protein (WFA(+)-M2BP) level on survival comparing with other laboratory liver fibrosis markers in hepatitis C virus (HCV)-related compensated liver cirrhosis (LC) (n = 165). For assessing prognostic performance o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Kunihiro, Takata, Ryo, Nishikawa, Hiroki, Enomoto, Hirayuki, Ishii, Akio, Iwata, Yoshinori, Miyamoto, Yuho, Ishii, Noriko, Yuri, Yukihisa, Nakano, Chikage, Nishimura, Takashi, Yoh, Kazunori, Aizawa, Nobuhiro, Sakai, Yoshiyuki, Ikeda, Naoto, Takashima, Tomoyuki, Iijima, Hiroko, Nishiguchi, Shuhei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037777/
https://www.ncbi.nlm.nih.gov/pubmed/27626413
http://dx.doi.org/10.3390/ijms17091500
Descripción
Sumario:We aimed to examine the effect of Wisteria floribunda agglutinin-positive Mac-2-binding protein (WFA(+)-M2BP) level on survival comparing with other laboratory liver fibrosis markers in hepatitis C virus (HCV)-related compensated liver cirrhosis (LC) (n = 165). For assessing prognostic performance of continuous fibrosis markers, we adapted time-dependent receiver operating characteristics (ROC) curves for clinical outcome. In time-dependent ROC analysis, annual area under the ROCs (AUROCs) were plotted. We also calculated the total sum of AUROCs in all time-points (TAAT score) in each fibrosis marker. WFA(+)-M2BP value ranged from 0.66 cutoff index (COI) to 19.95 COI (median value, 5.29 COI). Using ROC analysis for survival, the optimal cutoff point for WFA(+)-M2BP was 6.15 COI (AUROC = 0.79348, sensitivity = 80.0%, specificity = 74.78%). The cumulative five-year survival rate in patients with WFA(+)-M2BP ≥ 6.15 COI (n = 69) was 43.99%, while that in patients with WFA(+)-M2BP < 6.15 COI (n = 96) was 88.40% (p < 0.0001). In the multivariate analysis, absence of hepatocellular carcinoma (p = 0.0008), WFA(+)-M2BP < 6.15 COI (p = 0.0132), achievement of sustained virological response (p < 0.0001) and des-γ-carboxy prothrombin < 41 mAU/mL (p = 0.0018) were significant favorable predictors linked to survival. In time-dependent ROC analysis in all cases, WFA(+)-M2BP had the highest TAAT score among liver fibrosis markers. In conclusion, WFA(+)-M2BP can be a useful predictor in HCV-related compensated LC.